tirzepatide glp-1 gip Research Peptide | cGMP Semaglutide or Tirzepatide—which is right

Convenience and Care: Through telemedicine, we simplify the process of starting and maintaining your treatment, with ongoing virtual consultations and prescription services

Patients may meticulously log solid foods while overlooking protein shakes, coffee beverages, alcohol, or juice

Tirzepatide, the first drug in a novel family of medicines targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), has captured attention for its potential to not only regulate blood sugar levels but also induce significant weight loss

Key Findings Mean weight loss was 20.2 percent with tirzepatide compared to 13.7 percent with semaglutide, a statistically and clinically significant difference